Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study
This study aims to investigate the potential anticancer effects of erucin, an isothiocyanate derived from <i>Eruca sativa</i>, in triple-negative breast cancer (TNBC) by predicting molecular targets and evaluating its in vitro effects on TNBC cell proliferation, apoptosis and cell cycle distribution...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2026-04-01
|
| Серии: | Life |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2075-1729/16/5/708 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
